Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein antibody demyelinating neuropathy

Marinos C. Dalakas, Goran Rakocevic, Mohammad Salajegheh, James M. Dambrosia, Angelika F. Hahn, Raghavan Raju, Beverly McElroy

Research output: Contribution to journalArticle

198 Scopus citations

Fingerprint Dive into the research topics of 'Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein antibody demyelinating neuropathy'. Together they form a unique fingerprint.

Medicine & Life Sciences